Results
1
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
1 companies
Kuros Biosciences
Market Cap: CHF 1.1b
Engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally.
KURN
CHF 27.30
7D
-4.9%
1Y
-6.5%